Your browser doesn't support javascript.
loading
FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.
Campos Carrascosa, Lucia; van Beek, Adriaan A; de Ruiter, Valeska; Doukas, Michail; Wei, Jie; Fisher, Timothy S; Ching, Keith; Yang, Wenjing; van Loon, Karlijn; Boor, Patrick P C; Rakké, Yannick S; Noordam, Lisanne; Doornebosch, Pascal; Grünhagen, Dirk; Verhoef, Kees; Polak, Wojciech G; IJzermans, Jan N M; Ni, Irene; Yeung, Yik Andy; Salek-Ardakani, Shahram; Sprengers, Dave; Kwekkeboom, Jaap.
Afiliação
  • Campos Carrascosa L; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • van Beek AA; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • de Ruiter V; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Doukas M; Pathology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Wei J; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • Fisher TS; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • Ching K; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • Yang W; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • van Loon K; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Boor PPC; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Rakké YS; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Noordam L; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Doornebosch P; Surgery, IJsselland Hospital, Capelle aan den IJssel, Netherlands.
  • Grünhagen D; Surgery, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Verhoef K; Surgery, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Polak WG; Surgery, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • IJzermans JNM; Surgery, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Ni I; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • Yeung YA; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • Salek-Ardakani S; Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA.
  • Sprengers D; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands.
  • Kwekkeboom J; Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, Netherlands j.kwekkeboom@erasmusmc.nl.
J Immunother Cancer ; 8(2)2020 09.
Article em En | MEDLINE | ID: mdl-32900860
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfócitos do Interstício Tumoral / Receptores OX40 / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfócitos do Interstício Tumoral / Receptores OX40 / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article